Hypersoniq has successfully raised €1.1 million in funding to accelerate its growth and enhance its innovative Electrochemical Impedance Spectroscopy technology.
Information on the Target
Hypersoniq, founded in 2020 and based in Delft, Netherlands, has developed a cutting-edge technology known as Electrochemical Impedance Spectroscopy (EIS). This innovative method investigates the electrochemical properties of liquids by applying an alternating current signal across a range of frequencies. As a result, EIS produces a distinct Fluid Fingerprint Spectrum that encapsulates vast amounts of data regarding the analyzed fluid.
Utilizing advanced analytical techniques, Hypersoniq is able to deconvolute this data, extracting meaningful insights to address customer-specific challenges. This proprietary technology positions Hypersoniq as a leader in the field, offering unique solutions for various sectors that require in-depth fluid analysis.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The Netherlands has a dynamic technology landscape, particularly in the field of analytical science and engineering. With a strong emphasis on research and development, the country is at the forefront of innovati
Similar Deals
NAP (formerly Cavalry Ventures) → beSirius
2025
Chrysalix Venture Capital → C2CA Technology
2023
SHIFT’s Thematic Technology Transfer Circular fund and angel investor Jeroen van Rotterdam → Nature's Principles
2023
VP Capital
invested in
Hypersoniq
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $1M